PLAAT4 antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphotidylcholines(PC) and phosphatidylethanolamine(PE). For most substrates, PLA1 activity is much higher than PLA2 activity. N-and O-acylation activity is hardly detectable.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | retinoic acid receptor responder(tazarotene induced) 3 (PLAAT4) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | WB: 1:500-1:2000; IHC: 1:20-1:200 |
| Clonality | polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Observed MW | 18 kDa |
| Purity | ≥95% as determined by SDS-PAGE |
| Purification | Immunogen affinity purified |
| Size 1 | 100µg |
| Form | liquid |
| Tested Applications | ELISA, IHC, WB |
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| UniProt ID | Q9UL19 |
| Gene ID | 5920 |
| Alias | Phospholipase A and acyltransferase 4,HRAS-like suppressor 4 (HRSL4),RAR-responsive protein TIG3,Retinoic acid receptor responder protein 3,Retinoid-inducible gene 1 protein,Tazarotene-induced gene 3 protein,PLAAT4,RARRES3,RIG1,TIG3 |
| Background | Antibody anti-PLAAT4 |
| Status | RUO |
| Note | Mol. Weight 18 kDa |
Descripción
Related Products
Human RARRES3 (Phospholipase A and acyltransferase 4) ELISA Kit
Ver Producto
PLAAT4 antibody
Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphotidylcholines(PC) and phosphatidylethanolamine(PE). For most substrates, PLA1 activity is much higher than PLA2 activity. N-and O-acylation activity is hardly detectable.
Ver Producto
Phospholipase A and Acyltransferase 4 / RARRES3 (PLAAT4) Antibody
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.
Ver Producto